Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Cardiology

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjcard.2012.02.040PMID 22464212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predicting Restenosis of Drug-Eluting Stents Placed in Real-World Clinical Practice: Derivation and Validation of a Risk Model From the EVENT Registry

  2010cited by this paper
• Comparison of plain balloon and cutting balloon angioplasty for the treatment of restenosis with drug-eluting stents vs bare metal stents.

  2010cited by this paper
• Drug-eluting versus bare-metal stents in unprotected left main coronary artery stenosis a meta-analysis.

  2010cited by this paper
• Angiographic predictors of recurrent stent thrombosis (from the Outcome of PCI for stent-ThrombosIs MultIcentre STudy [OPTIMIST]).

  2010cited by this paper
• Drug‐eluting stents versus bare‐metal stents for treatment of bare‐metal in‐stent restenosis

  2010cited by this paper
• Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.

  2009cited by this paper
• Drug-eluting or bare-metal stents for acute myocardial infarction.

  2008cited by this paper
• Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.

  2008cited by this paper
• Safety and efficacy update on first-generation drug-eluting stents.

  2008cited by this paper
• Comparison of short- and long-term outcomes between Cypher and TAXUS drug-eluting stents for in-stent restenosis.

  2007cited by this paper
• Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions

  2007cited by this paper
• Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial.

  2006cited by this paper
• A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

  2004cited by this paper
• Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

  2003cited by this paper
• Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.

  2002cited by this paper
• Long-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience.

  1987cited by this paper
• Transluminal dilatation of coronary-artery stenosis.

  1978cited by this paper
• Letter: Mobile coronary care.

  1974cited by this paper

• Routine stress testing with subsequent coronary angiography versus standard of care in high-risk patients after percutaneous coronary intervention: An updated meta-analysis of randomized controlled trials

  2025cites this paper
• Tooth Loss is a Risk Factor for Cardiovascular Disease Mortality: A Systematic Review with Meta-Analyses.

  2024cites this paper
• Association between Lipid Level and Revascularization at Routine Coronary Angiography Follow-up among Patients with Acute Coronary Syndrome: A Case-control Study

  2022cites this paper
• Cost-effectiveness of follow-up invasive coronary angiography after percutaneous coronary stenting: a real-world observational cohort study in Japan

  2022cites this paper
• Hospital-level variation in follow-up strategies after percutaneous coronary intervention, revealed in health claims data of Korea

  2021cites this paper
• Follow-up tests and outcomes for patients undergoing percutaneous coronary intervention: analysis of a Japanese administrative database

  2018cites this paper
• Routine angiographic follow-up versus clinical follow-up in patients with diabetes following percutaneous coronary intervention with drug-eluting stents in Korean population.

  2018cites this paper
• Routine Angiographic Follow-Up After Coronary Artery Disease Revascularization: Is Seeing Believing?

  2018cites this paper
• Clinical impact of routine angiographic follow-up after percutaneous coronary interventions on unprotected left main.

  2018cites this paper
• A multidirectional approach to risk assessment in patients with three-vessel coronary artery disease undergoing percutaneous intervention.

  2017cites this paper
• Role of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention　- Systematic Review and Meta-Analysis.

  2017cites this paper
• Routine Angiographic Follow-Up versus Clinical Follow-Up after Percutaneous Coronary Intervention in Acute Myocardial Infarction

  2017cites this paper
• The ReACT Trial: Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial.

  2017cites this paper
• Routine Surveillance Coronary Angiography Post-PCI: Should We ReACT and Change Our Routine?

  2017cites this paper
• Routine angiographic follow-up versus clinical follow-up in patients with multivessel coronary artery diseases following percutaneous coronary intervention with drug-eluting stents: a nested case–control study within a Korean population

  2017cites this paper
• The role of angiographic follow-up after percutaneous coronary intervention.

  2016cites this paper
• Randomized Evaluation of Routine Follow-up Coronary Angiography after Percutaneous Coronary Intervention Trial (ReACT)

  2016cites this paper
• Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis

  2016cites this paper
• Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting.

  2015cites this paper
• Clinical impact of routine follow-up coronary angiography after second- or third-generation drug-eluting stent insertion in clinically stable patients

  2014influential citation
• Impact of scheduled angiographic follow-up in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

  2013cites this paper
• Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).

  2013cites this paper